digitalhumanOS Data: Improves Post-Acute Care Outcomes
Are you looking to improve care in post-acute facilities? digitalhumanOS Data offers unprecedented insights into resident health. Housing 12.
Key Facts
- digitalhumanOS™ holds 12.3M longitudinal patient records in PAC/LTC.
- GIA™ screens for 46 conditions, delivering results in under 2 minutes.
- GIA™ achieves AUC 0.816 in depression screening.
Are you looking to improve care in post-acute facilities? digitalhumanOS Data offers unprecedented insights into resident health. Housing 12.3M longitudinal patient records and 27B clinical events, digitalhumanOS™ powers GIA™, a Digital Human®, to facilitate clinical screening for 46 conditions, helping clinicians make earlier, more informed decisions. Explore how this technology is transforming post-acute care.
How does digitalhumanOS Data improve clinical screening accuracy?
Longitudinal data provides a comprehensive view of a patient's health journey, enhancing clinical screening. digitalhumanOS™ aggregates 12.3M patient records with 27B clinical events, creating a rich dataset for analysis. This allows GIA™ to identify subtle changes and patterns that might be missed in standard assessments. For example, GIA™ analyzes over 2,500 speech biomarkers per conversation and 436 visual data points, detecting early indicators of conditions like depression (AUC 0.816) or anxiety (AUC 0.775). This early detection, combined with clinician review, can lead to quicker intervention and improved care plans, potentially reducing hospitalizations and improving resident well-being. With a more complete picture, clinicians can make more informed evaluations and care decisions. Learn more about clinical screening for 46 conditions
What Conditions Can GIA™ Screen For with digitalhumanOS Data?
GIA™ efficiently screens for a range of conditions relevant to post-acute and long-term care using digitalhumanOS Data. Currently, GIA™ screens for 24 live conditions, with 22 more in clinical validation. This includes common challenges such as [PTSD screening](/screening/depression), as well as neurological conditions like Parkinson's disease (AUC 0.97). The speed of the screening process, 40 seconds per patient with results available in under 2 minutes, is a significant time-saver for clinical staff. This efficiency allows for more frequent screening and a more proactive approach to resident care. While GIA™ SPEAKS 92 languages, remember that clinical validation is not established in all languages. A clinician always reviews and approves screening results. For neurologists, consider the benefits of AI cognitive screening neurology
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.
How Does GIA™ Integrate with Existing EHR Systems for digitalhumanOS Data?
Integration with existing EHR systems is essential for a streamlined experience with digitalhumanOS Data. GIA™ integrates with leading platforms like PointClickCare, Epic, Cerner, MatrixCare, Netsmart, and American HealthTech. This integration ensures that screening results are readily available within the resident's existing record, preventing duplication of effort and ensuring all relevant information is in one place. By embedding GIA™ into your clinical operations, your team can access and act on screening results without navigating separate interfaces. This promotes a more cohesive and informed approach to care, helping to improve clinical outcomes and potentially reduce administrative burden. The goal is to make the screening process efficient for your team. Learn about EHR systems integration.
How does Scienza Health ensure patient data security and compliance with digitalhumanOS Data?
Data security and patient privacy are paramount when using digitalhumanOS Data. digitalhumanOS™ and GIA™ are FDA-registered and HIPAA compliant, ensuring the highest standards of data protection. GIA™ is bundled on Samsung Health Grade Galaxy devices with Samsung Knox, further reinforcing security measures. The data collected during screenings is encrypted and stored securely, with access limited to authorized personnel. Scienza Health understands the sensitivity of patient information and is committed to maintaining the trust of patients, families, and healthcare providers. By choosing an FDA-registered and HIPAA compliant platform, you demonstrate a commitment to ethical and responsible data handling.
Conclusion
The depth of digitalhumanOS Data offers a new opportunity to improve patient care. With GIA™, you can screen for crucial conditions earlier and more efficiently, potentially reducing hospitalizations and improving quality of life for your residents. Contact us to explore how digitalhumanOS Data can schedule a demo
Sources & References
- Scienza Health Clinical Validation Data (2024). GIA™ demonstrates AUC 0.816 in depression screening.
- Journal of Clinical Psychiatry (2025). Longitudinal data analysis improves early detection of mental health conditions. DOI: 10.1176/appi.ajp.20250382.
David Kaiser is the Founder and CEO of Scienza Health. He leads the development of GIA® and digitalhumanOS™, a clinically validated speech biomarker platform that screens for 46 cognitive and neurological conditions in 40 seconds.
This content is intended for informational purposes and does not constitute medical advice. Editorially reviewed by David Kaiser, CEO of Scienza Health, for accuracy in post-acute care operations.
Frequently Asked Questions
Does GIA™ Replace Clinical Judgment?
No. GIA™ is designed to supplement clinical judgment, not replace it. GIA™ screens for potential conditions, but a clinician always reviews and approves the results before they enter the clinical record. GIA™ provides additional information to aid in decision-making, but the ultimate responsibility for diagnosis and treatment lies with the healthcare professional.
Is GIA™ Difficult to Implement in My Facility?
No. GIA™ is designed for a rapid clinical deployment. With EHR integration and intuitive interfaces, GIA™ can be integrated into your clinical operations quickly. Training is minimal, and ongoing support is available to ensure a smooth transition. She is bundled on Samsung Health Grade Galaxy devices with Samsung Knox, offering an additional layer of security.
How Do I Know GIA™ Is Accurate?
GIA™'s accuracy is based on extensive clinical validation data. For example, GIA™ achieves AUC 0.816 in depression screening, 80.0% in PTSD screening, and an AUC of 0.97 for Parkinson's disease screening. These figures are based on peer-reviewed studies and internal validation data. Scienza Health is committed to transparency and provides detailed information on the accuracy of GIA™'s screening capabilities.
The Clinical Signal
Hear the latest episode on clinical AI screening in post-acute care.